Is it more important to quit smoking than which chemotherapy is used?

Many patients continue to smoke after their diagnosis of cancer. It is a critically important time to work with the patient to have them stop smoking. Many oncologists may underestimate the potential interactions of smoking with their anti-tumor therapy. The detrimental possibilities are examined as...

Full description

Saved in:
Bibliographic Details
Published inLung cancer (Amsterdam, Netherlands) Vol. 39; no. 2; pp. 119 - 124
Main Author Dresler, Carolyn M
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 01.02.2003
Elsevier Science
Subjects
Antineoplastic Agents - therapeutic use
Biological and medical sciences
Drug or therapy interactions
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - etiology
Medical sciences
Nicotine
Pneumology
Smoking
Smoking - adverse effects
Smoking Cessation
Tumors of the respiratory system and mediastinum
Drug or therapy interactions
Smoking
Nicotine
Human
Lung disease
Prognosis
Respiratory disease
Weaning
Tobacco smoking
Malignant tumor
Bronchopulmonary
Alkaloid
Treatment
Bronchus disease
Online AccessGet full text

Cover

More Information
Summary:Many patients continue to smoke after their diagnosis of cancer. It is a critically important time to work with the patient to have them stop smoking. Many oncologists may underestimate the potential interactions of smoking with their anti-tumor therapy. The detrimental possibilities are examined as they relate to surgery, radiation and most importantly, to chemotherapy. Oncologists must become more active in working with their continuing smokers in order to aid in their response to interventions. Documentation of smoking status is critical to report in future studies that have evaluated therapeutic options.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0169-5002
1872-8332
DOI:10.1016/S0169-5002(02)00455-5